Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 43/100 | DilutionWatch score record |
| Shares Outstanding | 89.87M | Verified float table or market cache |
| Public Float | Not available | Verified float table or market cache |
| Market Cap | $1.73B | Market data cache |
| Cash Runway | 23.5 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | None in current score inputs | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 1.
Recent SEC source mix: XBRL 1.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
BRVE SEC Filing Activity — Last 12 Months
Shares outstanding reported by BRVE on the cover page of its latest 10-K/10-Q: 89.87M as of November 06, 2026.
DilutionWatch recorded no shelf, registration or prospectus documents for BRVE in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| 8-K | current report (material event) | 3 | Nov 10, 2026 |
| 10-Q | quarterly report | 2 | Nov 10, 2026 |
| SC 13D/A | amended >5% holder filing | 1 | Sep 10, 2026 |
| SC 13G | passive >5% holder filing | 4 | Nov 16, 2026 |
| 4 | insider transaction | 5 | Aug 11, 2026 |
Institutional Holdings
Short Interest
Recent SEC Activity
Recent News
Factual BRVE Dilution Snapshot
Braveheart Bio, Inc. (BRVE) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: November 21, 2026.
- Recent SEC activity tracked for BRVE: xbrl on 2026-11-10.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
BRVE's DilutionScore is currently 43/100 (Medium risk), with 3 score changes tracked over 90 days. The score improved from 37/100 (Medium risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Nov 17 – Nov 21, 2026 | 43/100 | MEDIUM | 5 days |
| Oct 05 – Nov 16, 2026 | 37/100 | MEDIUM | 43 days |
| Sep 18 – Oct 04, 2026 | 48/100 | MEDIUM | 17 days |
| Aug 24 – Sep 17, 2026 | 40/100 | MEDIUM | 25 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
BRVE shares outstanding have decreased 0.2% from 90.04M (Nov 2026) to 89.87M (Nov 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| Nov 17, 2026 | 89.87M | — | — |
| Nov 10, 2026 | 90.04M | — | — |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.